Go Back

AliveCor Continues To Improve Its Service Offerings

SAN FRANCISCO, Calif. March 18, 2014

Over-the-Counter Orders Start Shipping Today

AliveCor, Inc. announced today that over-the-counter (OTC) orders for the AliveCor® Heart Monitor, the only FDA cleared mobile ECG (electrocardiogram) recorder that supports both iPhone and Android smartphones, previously available by prescription only, will begin shipping today.

The AliveInsights™ service has also been expanded to include an education service. The educational portal provides patients with access to information about cardiac anatomy, description of an ECG, and an arrhythmia library, which includes a comprehensive database of information providing patients additional tools to encourage more patients to learn more about their heart health.

“Providing patients with an over-the-counter device and comprehensive educational information will provide the tools needed for patients to fully participate in their own cardiac health,” said Euan Thomson, president and chief executive officer of AliveCor. “The physician’s role is still key to managing the patients overall health and understanding the data provided by our device. It is our hope that the AliveCor Heart Monitor will facilitate collaboration and make access to mobile healthcare as seamless as possible for all users.”

The AliveCor Heart Monitor is the only FDA cleared mobile ECG recorder that supports both iPhone and Android smartphones. It records, displays (when prescribed or used under the care of a physician) stores, and transfers single-channel ECG rhythms wirelessly, using the free AliveECG app. With secure storage in the cloud, users can access their data confidentially anytime, anywhere, and can grant access to their physician. The Heart Monitor is available for purchase in the United States by health professionals and consumers.

Most Recent

November 10, 2023

AliveCor Appoints Michael Rolla as Chief Revenue Officer, Enterprise

Read More

September 27, 2023

AliveCor's KardiaMobile® 6L Becomes First Personal ECG Device Recommended for Use in Psychiatric Services in England and Wales

Read More

July 26, 2023

AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

Read More

Let's transform cardiovascular care together

If you are an employer or payer looking for a comprehensive heart health enterprise solution, contact us.